Karlye is grateful that she's been able to pursue her passions, including sports and international travel, while growing up navigating PKU. Now as an adult, she is leaning into sharing her journey with the hope of helping others living with this rare metabolic condition.

We're pleased to announce that Inozyme Pharma is now a wholly owned subsidiary of BioMarin Pharmaceutical Inc. We look forward to advancing our shared mission in translating the promise of genetic discovery into medicines that make a profound impact on the life of each patient.

Shola Fafunso is the U.S. country lead for the Skeletal Conditions business unit, responsible for driving the commercial efforts and aligning cross-functional teams to achieve business performance within this therapeutic area. But it's the patients who serve as his North Star.

In celebration of Pride Month, employees raised the Progress Pride Flag at our San Rafael and Novato campuses to symbolize visibility and allyship. We shared laughter and connection at our Pride lunches and gathered for a thoughtful fireside chat on “Unmasking Identity.” During this conversation, our colleagues shared their personal stories about embracing their authentic selves at work.